Search Articles
Search results
Displaying 41 - 60 of 1617
Cancer,
Science & Research
Researchers uncover a potential genetic marker associated with better survival outcomes in patients with head and neck cancer
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center discovered a gene usually linked to giant axonal neuropathy, a rare neurological condition, also plays a role in inhibiting aggressive tumor cell growth in head and neck cancers.
February 29, 2024
|
3 min read
Cancer
30 years and counting: Simms Mann UCLA Center for Integrative Oncology is a national model for whole-person cancer care
When the father of Victoria Mann Simms, PhD, was diagnosed with cancer in the early 1990s, integrative care was virtually non-existent.
February 28, 2024
|
7 min read
Ask the Doctors,
Cancer,
Science & Research
Researchers use AI to detect pancreatic cancer sooner
A dear friend was diagnosed with pancreatic cancer. It was so advanced, he died just a month later. I recently saw a discussion on television about using AI to detect pancreatic cancer early, while it is still curable. How would that work?
February 26, 2024
|
3 min read
Behavioral Health,
Science & Research
Yoga provides unique cognitive benefits to older women at risk of Alzheimer’s disease, study finds
February 23, 2024
|
3 min read
Behavioral Health
Dr. Yonca Bulut is spreading the message about the need for global pediatric disaster preparedness
February 23, 2024
|
5 min read
Cancer,
Science & Research
Off-the-shelf vaccine offers hope for pancreatic and colorectal cancer patients with KRAS mutations
Samara Rahman, 74, enrolled in a clinical trial at UCLA Health that was evaluating an “off-the-shelf” vaccine that is given after surgery to prevent or delay the cancer from coming back in high-risk patients.
February 22, 2024
|
5 min read
Cancer,
Healthy Lifestyle
What you need to know about cancer and nutrition: March webinar
Simms Mann UCLA Center for Integrative Oncology is launching a monthly education webinar - Nutrition & Cancer: What You Need to Know. This is designed to shed light on the complex topic of nutrition for cancer survivors.
February 21, 2024
|
3 min read
Behavioral Health,
Science & Research
Uptake of HIV prevention medication doubles with mix of digital health interventions, study finds
February 20, 2024
|
4 min read
Cancer
Turning a Cancer Diagnosis into Life-Affirming Giving
Friends - U Magazine Winter 2024
February 16, 2024
|
4 min read
Cancer
This revolutionary breast cancer drug has saved millions of lives in its 25-year history
UCLA Health oncologist Dr. Dennis Slamon and his team brought forward Herceptin, the first FDA-approved gene-based drug to fight cancer, back in 1988.
February 16, 2024
|
6 min read
Cancer,
Science & Research
Promising target for CAR T-cell therapy leads to potent antitumor responses against cutaneous and rare melanomas
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new CAR T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.
February 16, 2024
|
4 min read
Cancer
Chaplain Michael Eselun helps people address the big spiritual questions that often accompany a cancer diagnosis
February 15, 2024
|
6 min read
Cancer,
Science & Research
UCLA-led research results in FDA approval of 4-drug combination for frontline treatment of metastatic pancreatic cancer
A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil has been approved by the FDA for the first-line treatment of metastatic pancreatic adenocarcinoma.
February 15, 2024
|
3 min read
Behavioral Health,
Healthy Lifestyle
Do unresolved trauma and dementia have a link?
February 13, 2024
|
3 min read
Behavioral Health,
Science & Research
Study finds childhood bullying linked to distrust and mental health problems in adolescence
February 13, 2024
|
3 min read
Cancer,
Science & Research
Antibody drug conjugates make strides in ovarian cancer with recent FDA approval
The UCLA Health women’s cancer research team in OBGYN played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate for the treatment of platinum-resistant ovarian cancer.
February 12, 2024
|
4 min read
Behavioral Health
Creating an all-electric kitchen at UCLA Health’s new neuropsychiatric hospital
February 8, 2024
|
3 min read
Behavioral Health
Super Bowl gambling: Does America have a problem?
February 7, 2024
|
6 min read
Behavioral Health,
Science & Research
Study finds LA County pilot program to aid gravely disabled residents could improve housing, hospitalization rates
A UCLA Health-led evaluation of Los Angeles County’s pilot program aimed at bolstering aid to gravely disabled homeless residents found the initiative could offer a promising framework to improve housing and health outcomes and relieve overburdened psychiatric hospitals.
February 5, 2024
|
4 min read
Cancer,
Science & Research
Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas
Investigators have identified a protein in highly aggressive neuroendocrine carcinomas and neuroblastoma that could potentially be used as a molecular biomarker for diagnosing these cancers and predicting and monitoring responses to therapy.
January 29, 2024
|
4 min read